Silver nanoparticles (AgNPs) as a contrast agent for imaging of animal tissue using swept-source optical coherence tomography (SSOCT) I Mondal, S Raj, P Roy, R Poddar Laser Physics 28 (1), 015601, 2017 | 19 | 2017 |
Potential of microRNA based diagnostics and therapeutics in glioma: a patent review I Mondal, R Kulshreshtha Expert Opinion on Therapeutic Patents 31 (1), 91-106, 2021 | 18 | 2021 |
Development of novel ruthenium (ii)–arene complexes displaying potent anticancer effects in glioblastoma cells P Kumar, I Mondal, R Kulshreshtha, AK Patra Dalton Transactions 49 (38), 13294-13310, 2020 | 17 | 2020 |
MicroRNA therapeutics in glioblastoma: Candidates and targeting strategies I Mondal, S Sharma, R Kulshreshtha AGO-Driven Non-Coding RNAs, 261-292, 2019 | 11 | 2019 |
TiO2 nanoparticles as exogenous contrast agent for 1 µm swept source optical coherence tomography: an in vitro study A Kumar, I Mondal, P Roy, R Poddar Laser Physics 28 (3), 035601, 2018 | 10 | 2018 |
Engineered smart materials for RNA based molecular therapy to treat Glioblastoma RR Singh, I Mondal, T Janjua, A Popat, R Kulshreshtha Bioactive Materials 33, 396-423, 2023 | 5 | 2023 |
Coagulation profile in patients suffering from acute brucellosis I Mondal, S Sanyal, S Das Asian J Pharm Clin Res 6, 179-80, 2013 | 3 | 2013 |
Hyphenation of lipophilic ruthenium (ii)-diphosphine core with 5-fluorouracil: an effective metallodrug against glioblastoma brain cancer cells A Saha, I Mondal, A Kumari, AK Sonkar, R Mishra, R Kulshreshtha, ... Dalton Transactions 53 (4), 1551-1567, 2024 | 2 | 2024 |
Transglutaminase-Polyethyleneimine Nanoflowers Mediated Cellular Delivery of Anti-miR-210 for Effective Glioblastoma Therapy I Mondal, SW Fatima, S Priya, S Sengupta, SK Khare, R Kulshreshtha ACS Biomaterials Science & Engineering 9 (5), 2558-2571, 2023 | 2 | 2023 |